Sort
146,196 grants matching “diabetes”
MicroRNA-based Radiation Biodosimeter (MiRAD) Phase II
$999,895Claude J. Rogers · Chromologic, Llc · R44 · FY2020 · AI
Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts
$999,893Bernhard Josef Hering · University Of Minnesota · U01 · FY2015 · AI
MicroRNA-based Radiation Biodosimeter (MiRAD) Phase II
$999,884Claude J. Rogers · Chromologic, Llc · R44 · FY2018 · AI
Clinical Evaluation of a Long Term Implanted Glucose Sensor
$999,876Joseph Y. Lucisano · Glysens, Inc. · R44 · FY2014 · DK
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery
$999,864Jerzy Szewczyk · Biokier, Inc. · R44 · FY2019 · DK
A Bullet Proof vascular graft to prevent dialysis access cannulation injury
$999,841Joseph Knight · Innavasc Medical, Inc. · R44 · FY2020 · DK
Development of a novel therapeutic for the treatment of diabetic nephropathy and renal fibrosis
$999,838Fabio Cohen Tucci · Epigen Biosciences, Inc. · R44 · FY2020 · DK
SBIR Phase II: Flexible Thin-Film Thermoelectric Wearable Energy Harvester
$999,834Marcus Ward · Perpetua Power Source Technologies, Inc. · · FY2011 · TIP
Anti-hIAPP for the preservation of pancreatic function in Type 2 Diabetes
$999,828Joana M Murad · Celdara Medical, Llc · R44 · FY2024 · DK
Menopausal Sleep Fragmentation: Impact on Body Fat Gain Biomarkers in Women
$999,817Hadine Joffe · Brigham And Women'S Hospital · R01 · FY2019 · AG
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery
$999,795Jerzy Szewczyk · Biokier, Inc. · R44 · FY2020 · DK
Portable Gas Perfusion System for Pancreas Preservation
$999,784Linda A Tempelman · Giner, Inc. · R44 · FY2014 · DK
IND-enabling studies of D6PV- a novel ApoC-II peptide mimetic therapeutic
$999,776Matt Devalaraja · Protean Bio Inc. · R44 · FY2025 · DK
Development of MRS-2541, a methionyl-tRNA synthetase inhibitor, for Gram positive bacterial infections.
$999,765Elke Lipka · Tsrl, Inc. · R44 · FY2025 · AI
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery
$999,710Jerzy Szewczyk · Biokier, Inc. · R44 · FY2021 · DK
Development of Chemistry, Manufacturing, and Control Standards for PGC and PGC-dANP
$999,661Gerardo M. Castillo · Pharmain Corporation · R44 · FY2017 · HL
Bedside to bench resources for lower urinary tract research
$999,601Douglas William Strand · Ut Southwestern Medical Center · RC2 · FY2025 · DK
Population-based Diabetes Youth Registry
$999,597Lynne E Wagenknecht · Wake Forest University Health Sciences · U18 · FY2017 · DP
SBIR Phase II: Innovative software and database tools for targeted genomics
$999,594Jill Pecon-Slattery · Cornerstone Genomics Llc · · FY2020 · TIP
SBIR Phase II: Ecosystem Design Tool
$999,592Daniel Fleischer · Hyphae Design Lab · · FY2023 · TIP
Development of a novel therapeutic for the treatment of diabetic nephropathy and renal fibrosis
$999,500Fabio Cohen Tucci · Epigen Biosciences, Inc. · R44 · FY2018 · DK
Dual Agonist Insulins for Treating Diabetics with Impaired Awareness ofHypoglycemia (IAH)
$999,468Pawel Fludzinski · Amidebio, Llc · R44 · FY2025 · DK
Component A: Impact of Community Factors on Geographic Disparities in Diabetes and Obesity Nationwide
$999,457Lorna Thorpe · New York University School Of Medicine · U01 · FY2020 · DP
Partnership for Public Health Research in the Oglala Sioux Tribe
$999,440Nancy Rumbaugh Whitesell · University Of Colorado Denver · RC4 · FY2010 · DA
Anti-hIAPP for the preservation of pancreatic function in Type 2 Diabetes
$999,432Joana M Murad · Celdara Medical, Llc · R44 · FY2023 · DK